Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VALACYCLOVIR Cause Febrile bone marrow aplasia? 47 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Febrile bone marrow aplasia have been filed in association with VALACYCLOVIR (Valacyclovir Hydrochloride). This represents 0.4% of all adverse event reports for VALACYCLOVIR.

47
Reports of Febrile bone marrow aplasia with VALACYCLOVIR
0.4%
of all VALACYCLOVIR reports
5
Deaths
40
Hospitalizations

How Dangerous Is Febrile bone marrow aplasia From VALACYCLOVIR?

Of the 47 reports, 5 (10.6%) resulted in death, 40 (85.1%) required hospitalization, and 4 (8.5%) were considered life-threatening.

Is Febrile bone marrow aplasia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VALACYCLOVIR. However, 47 reports have been filed with the FAERS database.

What Other Side Effects Does VALACYCLOVIR Cause?

Acute kidney injury (978) Drug ineffective (894) Off label use (593) Pyrexia (551) Drug reaction with eosinophilia and systemic symptoms (496) Confusional state (456) Rash (423) Nausea (415) Neurotoxicity (404) Altered state of consciousness (395)

What Other Drugs Cause Febrile bone marrow aplasia?

VINCRISTINE (912) METHOTREXATE (880) CYCLOPHOSPHAMIDE (839) CYTARABINE (733) PEGASPARGASE (668) DOXORUBICIN (623) DEXAMETHASONE (555) CARBOPLATIN (440) ETOPOSIDE (413) HYDROCORTISONE (379)

Which VALACYCLOVIR Alternatives Have Lower Febrile bone marrow aplasia Risk?

VALACYCLOVIR vs VALBENAZINE VALACYCLOVIR vs VALBENAZINE DITOSYLATE VALACYCLOVIR vs VALDECOXIB VALACYCLOVIR vs VALERIAN VALACYCLOVIR vs VALGANCICLOVIR

Related Pages

VALACYCLOVIR Full Profile All Febrile bone marrow aplasia Reports All Drugs Causing Febrile bone marrow aplasia VALACYCLOVIR Demographics